Nexentis Technologies Inc.
Key Metrics
Market Snapshot
About
Nexentis Technologies Inc (NXTS) is a biotechnology company based in Ness Ziona, Israel, primarily focused on developing computational and experimental platforms for researching therapeutics for cancer and inflammatory metabolic diseases.
The company operates through two segments: Biotechnology Activity and Renewable Energy Projects. Its core biotechnology work involves building a pipeline of preclinical research tools and assets. These include MITOLINE, an algorithmic platform designed to model mitochondrial carrier proteins, which are potential drug targets. Nexentis also develops a cloud-based computational chemistry platform for molecular analysis, novel in-vitro screening systems, and advanced three-dimensional tumor spheroid models, such as for non-small cell lung cancer, to study drug responses in a lab setting.
The Renewable Energy Projects segment represents a separate line of business. While specific project details are not disclosed, this segment indicates the company's broader operational scope beyond life sciences. Nexentis Technologies was incorporated in 2009 and was formerly known as N2OFF, Inc. before changing its name in February 2026, reflecting its evolving strategic focus on technology-driven therapeutic research.